Amgen Jövedelem
Mi az Amgen Jövedelem?
A Jövedelem az Amgen, Inc. - -$24.93
Mi a Jövedelem meghatározása?
A közös részvényesek számára rendelkezésre álló nettó jövedelem egyenlő a nettó jövedelemmel mínusz a kifizetett előnyben részesített osztalékokkal.
Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders' claim on the company's cash flows.
Jövedelem a Health Care szektor a XETRA-on cégekben a Amgen -hoz képest
Mit csinál Amgen?
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and a strategic research and development collaboration with Neumora Therapeutics, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
jövedelem -hoz hasonló cégek Amgen
- Matrix Service Co nak Jövedelem -$24.98 van
- comScore nak Jövedelem -$24.98 van
- Aptevo Therapeutics Inc nak Jövedelem -$24.95 van
- AusCann Ltd nak Jövedelem -AUD$24.94 van
- AusCann nak Jövedelem -AUD$24.94 van
- Quantum Genomics SA nak Jövedelem -€24.94 van
- Amgen nak Jövedelem -$24.93 van
- Atari SA nak Jövedelem -€24.90 van
- Eltel AB (publ) nak Jövedelem -€24.90 van
- Blackstone Minerals nak Jövedelem -AUD$24.90 van
- P2P Transport nak Jövedelem -AUD$24.86 van
- Asiasec Properties nak Jövedelem -HKD$24.84 van
- Staffing 360 Solutions Inc nak Jövedelem -$24.83 van